Morning Briefing
Summaries of health policy coverage from major news organizations
Patients, Scientists In Different Corners For Cancer Drug Fight
The drug, Avastin, will be the subject of an unusual Food and Drug Administration hearing to revisit a panel vote last July that steered many doctors away from prescribing the drug for the treatment of breast cancer.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
